Bolar
Executive Summary
Generic firm agrees to pay $7 mil. to Warner-Lambert to settle lawsuit concerning damages to the brandname drugs caused by fraudulently approved ANDAs for Dilantin, Meclomen and Procain ("The Pink Sheet" Oct. 21, T&G-13), Bolar announced Feb. 3. Warner-Lambert filed suit in Newark, N.J. federal court last autumn against Bolar and the company's former President Robert Shulman. Bolar has agreed to pay $1 mil. to Warner-Lambert upon the signing of the settlement, $2 mil. on or before March 1, 1992 and $1 mil. every 15 months until Jan. 1, 1997.